Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis

Tolou-Ghamari, 2016, Fingolimod for multiple sclerosis; mechanism of action, safety and toxicity, Arch. Neurosci., 3, 10.5812/archneurosci.31295 Tolou-Ghamari, 2016, Efficacy and toxicity of rituximab in multiple sclerosis, Arch. Neurosci., 3, 10.5812/archneurosci.30107 Tolou-Ghamari, 2015, A review of geoepidemiological differences of multiple sclerosis in Iran and other Middle East countries, Arch. Neurosci., 2 Kallaur, 2016, Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis, Mol. Neurobiol., 1 Wergeland, 2016, Vitamin D, HLA-DRB1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients, Eur. J. Neurol., 23, 1064, 10.1111/ene.12986 Elmongui, 2016, Association and linkage of definite multiple sclerosis with HLA and the potential protective role of helicobacter pylori infection among Egyptians, Int. Arch. Med., 9 Pugliese, 2016, The HLA-DRB1* 15: 01-DQA1* 01: 02-DQB1* 06: 02 haplotype protects autoantibody-positive relatives from type 1 diabetes throughout the stages of disease progression, Diabetes, 10.2337/db15-1105 Jucaud, 2016, Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: clinical relevance of HLA-F autoantibodies, Clin. Exp. Immunol., 183, 326, 10.1111/cei.12724 Sato, 2016, Cellular immunity and multiple sclerosis: current understanding, 3 Beigi Boroujeni, 2015, The effect of ethanolic extract of Salvia officinalis on the uterine natural killer cells population at day 7 of pregnancy, J. Med. Plants, 14, 15 Ghafourian, 2015, The role of CD16+, CD56+, NK (CD16+/CD56+) and B CD20+ cells in the outcome of pregnancy in women with recurrent spontaneous abortion, Int. J. Wom. Health Reprod. Sci., 3, 61, 10.15296/ijwhr.2015.10 Mousavi, 2009, Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients, Iran. J. Allergy Asthma Immunol., 8, 193 Ahmadi, 2016, A review on controversies about the role of immune and inflammatory systems in implantation process and durability of pregnancy, Int. J. Wom. Health Reprod. Sci., 4, 96, 10.15296/ijwhr.2016.24 Macchi, 2016, Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?, Neural Regen. Res., 11, 733, 10.4103/1673-5374.182695 Vandenbark, 2009, Interferon-beta-1a treatment increases CD56 bright natural killer cells and CD4+ CD25+ Foxp3 expression in subjects with multiple sclerosis, J. Neuroimmunol., 215, 125, 10.1016/j.jneuroim.2009.08.007 Schmalbrock, 2016, Basal ganglia iron in patients with multiple sclerosis measured with 7T quantitative susceptibility mapping correlates with inhibitory control, Am. J. Neuroradiol., 37, 439, 10.3174/ajnr.A4599 Magnano, 2016, Assessment of brainstem reflexes improves the diagnostic sensitivity of multimodal evoked potentials, MRI and clinical testing in the investigation of brainstem function in multiple sclerosis, Clin. Neurophysiol., 127 Casserly, 2016, MRI quantification of spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis (P3. 016), Neurology, 86 Gentile, 2016, Effects of siponimod (BAF312) on inflammation-driven synaptopathy in experimental multiple sclerosis (P5. 311), Neurology, 86 Antonio-Santos, 2016, Optical coherence tomography retinal nerve fiber analysis: a measure of axon loss in multiple sclerosis, Immunol. Infect. Dis., 4, 13 Tur, 2016, Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis, Brain, 10.1093/brain/awv396 Spadaro, 2016, Detection of autoantibodies against myelin oligodendrocyte glycoprotein in multiple sclerosis and related diseases, Mult. Scler. Methods Protoc., 99 Ludwin, 2016, Astrocytes in multiple sclerosis, Mult. Scler. J., 10.1177/1352458516643396 Minagar, 2003, Blood-brain barrier disruption in multiple sclerosis, Mult. Scler., 9, 540, 10.1191/1352458503ms965oa A. Varatharaj, I. Galea, The blood-brain barrier in systemic inflammation, Brain Behav. Immun., http://dx.doi.org/10.1016/j.bbi.2016.03.010 (in press). Fraussen, 2016, B cells and antibodies in progressive multiple sclerosis: contribution to neurodegeneration and progression, Autoimmun. Rev., 15, 896, 10.1016/j.autrev.2016.07.008 Gholami, 2016, Quercetin ameliorates peripheral nerve ischemia–reperfusion injury through the NF-kappa B pathway, Anat. Sci. Int., 1 Khalatbary, 2012, Neuroprotective effect of oleuropein following spinal cord injury in rats, Neurol. Res., 34, 44, 10.1179/1743132811Y.0000000058 Khalatbary, 2011, Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat, Iran. Biomed. J., 15, 31 Ahmadvand, 2016, Role of apoptosis in CNS emphasizing spinal cord injuries: a commentary, Iran. J. Neurosurg., 1, 30 Zipp, 2000, Apoptosis in multiple sclerosis, Cell Tissue Res., 301, 163, 10.1007/s004410000179 Haider, 2016, The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain, Brain, 139, 807, 10.1093/brain/awv398 Varzi, 2016, Distribution of HLA-DRB1 and HLA-DQB1 alleles in Lak population of Iran, Hum. Immunol., 77, 580, 10.1016/j.humimm.2016.05.011 Tajik, 2009, Distribution of KIR genes in the Iranian population, Tissue Antigens, 74, 22, 10.1111/j.1399-0039.2009.01263.x Mousavi, 2010, Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis, Iran. J. Immunol., 7, 88 Shahsavar, 2010, KIR2DS3 is associated with protection against acute myeloid leukemia, Iran. J. Immunol., 7, 8 Tajik, 2010, Compound KIR-HLA genotype analyses in the Iranian population by a ovel PCR-SSP assay, Int. J. Immunogenet., 37, 159, 10.1111/j.1744-313X.2010.00906.x Mousavi, 2011, Study of KIR expression and HLA ligands in CD56+lymphocytes of drug resistant tuberculosis patients, Iran. J. Allergy Asthma Immunol., 10, 189 Tajik, 2011, KIR3DL1+HLA-B Bw4 Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population, Int. J. Immunogenet., 38, 403, 10.1111/j.1744-313X.2011.01024.x Shahsavar, 2012, Association of KIR3DS1+HLA-B BW4lle8 combination with susceptibility to tuberculosis in Lur population of Iran, Iran. J. Immunol., 9, 39 Shahsavar, 2013, Distribution of KIR genes in the Lur population of Iran, Life Sci. J., 10, 11 Shahsavar, 2013, Donor KIR genotype with KIR2DS3 and/or KIR3DS1 increases survival after non-T-cell depleted HLA-identical sibling hematopoietic stem cell transplantation for acute myeloid leukemia, Life Sci. J., 10, 17 Fusco, 2010, KIRs and their HLA ligands in remitting–relapsing multiple sclerosis, J. Neuroimmunol., 229, 232, 10.1016/j.jneuroim.2010.08.004 Bettencourt, 2014, The role of KIR2DS1 in multiple sclerosis-KIR in Portuguese MS patients, J. Neuroimmunol., 269, 52, 10.1016/j.jneuroim.2014.01.009 Trachtenberg, 2009, Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosis, Ann. Neurol., 65, 626, 10.1002/ana.21747 Fogel, 2013, Natural killer cells in human autoimmune disorders, Arthritis Res. Ther., 15, 1, 10.1186/ar4232 Khaksari, 2015, Differential expression of CD16 and CD56 on natural killer (NK) cell subsets in multiple sclerosis and neuromyelitis optica, Int. J. Health Stud., 1, 1